IL149286A0 - Spiro(2h-1-benzopyran-2,4'-piperidine) derivatives as glycine transport inhibitors - Google Patents

Spiro(2h-1-benzopyran-2,4'-piperidine) derivatives as glycine transport inhibitors

Info

Publication number
IL149286A0
IL149286A0 IL14928600A IL14928600A IL149286A0 IL 149286 A0 IL149286 A0 IL 149286A0 IL 14928600 A IL14928600 A IL 14928600A IL 14928600 A IL14928600 A IL 14928600A IL 149286 A0 IL149286 A0 IL 149286A0
Authority
IL
Israel
Prior art keywords
benzopyran
spiro
piperidine
derivatives
transport inhibitors
Prior art date
Application number
IL14928600A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL149286A0 publication Critical patent/IL149286A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14928600A 1999-11-17 2000-11-13 Spiro(2h-1-benzopyran-2,4'-piperidine) derivatives as glycine transport inhibitors IL149286A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99309137 1999-11-17
PCT/EP2000/011351 WO2001036423A1 (en) 1999-11-17 2000-11-13 Spiro(2h-1-benzopyran-2,4'-piperidine) derivates as glycine transport inhibitors

Publications (1)

Publication Number Publication Date
IL149286A0 true IL149286A0 (en) 2002-11-10

Family

ID=8241739

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14928600A IL149286A0 (en) 1999-11-17 2000-11-13 Spiro(2h-1-benzopyran-2,4'-piperidine) derivatives as glycine transport inhibitors
IL149286A IL149286A (en) 1999-11-17 2002-04-23 History of Spiro (H2 1 - Benzopyran - 4,2 '- Piperidine) as Glycine Transfer Inhibitors

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL149286A IL149286A (en) 1999-11-17 2002-04-23 History of Spiro (H2 1 - Benzopyran - 4,2 '- Piperidine) as Glycine Transfer Inhibitors

Country Status (29)

Country Link
US (2) US6645973B1 (de)
EP (1) EP1232160B1 (de)
JP (1) JP4825386B2 (de)
KR (1) KR100776226B1 (de)
CN (1) CN1199974C (de)
AR (1) AR026487A1 (de)
AT (1) ATE398622T1 (de)
AU (1) AU779518B2 (de)
BR (1) BR0015586A (de)
CA (1) CA2389491C (de)
CO (1) CO5261618A1 (de)
CY (1) CY1108339T1 (de)
CZ (1) CZ293920B6 (de)
DE (1) DE60039247D1 (de)
DK (1) DK1232160T3 (de)
ES (1) ES2307536T3 (de)
HK (1) HK1047282B (de)
HU (1) HUP0204162A3 (de)
IL (2) IL149286A0 (de)
NO (1) NO327743B1 (de)
NZ (1) NZ518671A (de)
PE (1) PE20010750A1 (de)
PL (1) PL206071B1 (de)
PT (1) PT1232160E (de)
RU (1) RU2250211C2 (de)
SK (1) SK287040B6 (de)
TW (1) TWI243173B (de)
WO (1) WO2001036423A1 (de)
ZA (1) ZA200203320B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243173B (en) * 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
FR2842804B1 (fr) * 2002-07-29 2004-09-03 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
BRPI0415165A (pt) * 2003-10-01 2007-01-09 Adolor Corp composto heterocìclico espirocìclico, composição farmacêutica, método para ligar receptores opióides, métodos para prevenir ou tratar dor, disfunção gastrointestinal, um distúrbio do trato urogenital, um distúrbio imunomodulatório, um distúrbio inflamatório, um distúrbio de função respiratória, ansiedade, distúrbio do humor, um distúrbio relacionado a estresse, distúrbio do sistema nervoso simpático, tosse, e um distúrbio motor, método para tratar uma lesão traumática ao sistema nervoso central, métodos para prevenir ou tratar acidente vascular, arritmia cardìaca, glaucoma, e disfunção sexual, métodos para tratar uma condição selecionada do grupo consistindo de choque, edema cerebral, isquemia cerebral, déficit cerebral após cirurgia cardìaca (bypass) e enxerto, lupus eritematoso sistêmico, doença de hodgkin, doença de sjogren, epilepsia, e rejeição em transplantes de órgão e enxertos de pele, e para tratar dependência de substáncias, métodos para melhorar a sobrevivência de órgãos e células, e cardioproteção após infarto do miocárdio, métodos para reduzir a necessidade de anestesia, para produzir ou manter um estado anestésico, derivado radiomarcado de um composto, derivado isotopicamente marcado de um composto, composto e método de diagnóstico por imagem
EP1716147B1 (de) * 2004-01-08 2007-11-14 F.Hoffmann-La Roche Ag Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2
BRPI0418375A (pt) * 2004-01-08 2007-05-22 Hoffmann La Roche derivados de diaza-espiropiperidina
CA2609972C (en) * 2004-03-22 2013-05-14 Apkarian Technologies Llc Method and compositions for treatment of chronic neuropathic pain
US7598261B2 (en) * 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
CN101184749B (zh) * 2005-03-31 2012-12-05 阿得罗公司 螺环杂环衍生物及其使用方法
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
JP2009536175A (ja) * 2006-05-05 2009-10-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 特定の細胞サイクル酵素の阻害剤としてのスピロ−（ｔｈｏ）ベンゾピラン−２，４’−ピペリジン−及びシクロヘキサン誘導体
CN101534819A (zh) * 2006-09-12 2009-09-16 阿得罗公司 含氮的螺环化合物用于增强认知功能的应用
TWI366565B (en) 2007-06-06 2012-06-21 Otsuka Pharma Co Ltd Quinolone compound and pharmaceutical composition
KR100888468B1 (ko) * 2007-08-31 2009-03-11 한국화학연구원 항암활성을 갖는1'-알킬피페리딘-4'-스피로-2-6-(아미도)-2ｈ-벤조피란유도체
WO2009039431A2 (en) * 2007-09-21 2009-03-26 Neurogen Corporation Substituted aryl-fused spirocyclic amines
EP2380595A1 (de) 2010-04-19 2011-10-26 Nlife Therapeutics S.L. Zusammensetzungen und Verfahren zur selektiven Abgabe von Oligonukleotidmolekülen an spezifische Neuronentypen
TW201643169A (zh) * 2010-07-09 2016-12-16 艾伯維股份有限公司 作為s1p調節劑的螺-哌啶衍生物
US20170143681A1 (en) 2015-11-02 2017-05-25 Apkarian Technologies Llc Methods and compositions for treating pain
CN116621187B (zh) * 2023-07-24 2023-09-22 江苏泓顺硅基半导体科技有限公司 一种用于高温氯化提纯石英砂的设备

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
FR2689509B1 (fr) * 1992-04-01 1994-06-03 Adir Nouveaux derives spiraniques du 3-amino chromane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
IL107881A0 (en) * 1992-12-05 1994-04-12 Fisons Corp Furanone derivatives and pharmaceutical compositions containing them
WO1994018204A1 (en) * 1993-02-12 1994-08-18 Merck & Co., Inc. Spiro (2h-1-benzopyran-2, 4' piperidine) class iii antiarrhythmics
US5484923A (en) * 1993-06-10 1996-01-16 Merck & Co., Inc. Process of making spirocycles and analogs thereof
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
GB9421003D0 (en) * 1994-10-18 1994-12-07 Smithkline Beecham Plc Novel compounds
US5654316A (en) * 1995-06-06 1997-08-05 Schering Corporation Piperidine derivatives as neurokinin antagonists
EP0871440B1 (de) 1995-12-07 2006-03-22 Daniel C. Javitt Behandlung negativer und kognitiver symptome der schizophrenie mit antagonisten der glycinaufnahme
HUP9600928A3 (en) * 1996-04-10 1999-03-29 Richter Gedeon Vegyeszet Use of spiro[2h-1-benzopyran-2,4'-piperidin]-4(3h)-one derivatives for the preparation of pharmaceutical compositions treating dementia, novel derivatives and process for their preparation
WO1997045423A1 (en) 1996-05-31 1997-12-04 Trophix Neuroscience Inc. Pharmaceutical for treating of neurological and neuropsychiatric disorders
WO1997045115A1 (en) 1996-05-31 1997-12-04 Trophix Pharmaceuticals, Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
US5919653A (en) 1996-08-20 1999-07-06 Allelix Neuroscience Inc. Nucleic acids encoding a human glycine transporter
AU2030999A (en) 1998-01-09 1999-07-26 Allelix Neuroscience, Inc. Glycine transport inhibitors
TW555757B (en) 1998-07-31 2003-10-01 Akzo Nobel Nv Aminomethylcarboxylic acid derivatives
TWI243173B (en) * 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
CN1249057C (zh) * 2000-04-27 2006-04-05 巴斯利尔药物股份公司 用作抗菌剂的色烯基甲基嘧啶二胺

Also Published As

Publication number Publication date
CA2389491A1 (en) 2001-05-25
TWI243173B (en) 2005-11-11
DE60039247D1 (de) 2008-07-31
NO20022320L (no) 2002-05-15
NO327743B1 (no) 2009-09-14
JP2003527340A (ja) 2003-09-16
NO20022320D0 (no) 2002-05-15
PT1232160E (pt) 2008-09-30
ES2307536T3 (es) 2008-12-01
SK8432002A3 (en) 2002-10-08
IL149286A (en) 2008-08-07
CY1108339T1 (el) 2014-02-12
BR0015586A (pt) 2002-07-09
NZ518671A (en) 2003-10-31
ZA200203320B (en) 2003-08-27
CZ293920B6 (cs) 2004-08-18
CN1199974C (zh) 2005-05-04
HK1047282A1 (en) 2003-02-14
HUP0204162A2 (hu) 2003-04-28
JP4825386B2 (ja) 2011-11-30
WO2001036423A1 (en) 2001-05-25
ATE398622T1 (de) 2008-07-15
US20040029904A1 (en) 2004-02-12
HUP0204162A3 (en) 2006-01-30
SK287040B6 (sk) 2009-10-07
PL206071B1 (pl) 2010-06-30
RU2250211C2 (ru) 2005-04-20
CZ20021724A3 (cs) 2002-08-14
US6645973B1 (en) 2003-11-11
CN1390221A (zh) 2003-01-08
PL355975A1 (en) 2004-05-31
HK1047282B (zh) 2008-08-29
CO5261618A1 (es) 2003-03-31
AU1521901A (en) 2001-05-30
EP1232160A1 (de) 2002-08-21
CA2389491C (en) 2010-11-02
PE20010750A1 (es) 2001-07-19
KR100776226B1 (ko) 2007-11-16
KR20020050287A (ko) 2002-06-26
EP1232160B1 (de) 2008-06-18
US7507824B2 (en) 2009-03-24
AR026487A1 (es) 2003-02-12
AU779518B2 (en) 2005-01-27
DK1232160T3 (da) 2008-10-06

Similar Documents

Publication Publication Date Title
IL149286A0 (en) Spiro(2h-1-benzopyran-2,4'-piperidine) derivatives as glycine transport inhibitors
IL125589A0 (en) Pyrimidin-4-one derivatives as pesticides
HU9800138D0 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives
EP1208475A4 (de) System zur erhaltung von precomputerisierter sicht
HRP20020102B1 (en) Novel spiro compounds
IL157940A0 (en) Drugs containing triazaspiro [5.5] undecane derivatives as the active ingredient
IL147770A0 (en) 8-phenyl-6,9-dihydro-[1,2,4] triazolo[3,4-i] purin-5-one derivatives
SI0921125T1 (en) 1,3,8-Triazaspiro(4,5)decan-4-on derivatives
ZA200203003B (en) N-substituted carbamoyloxyalkyl-azolium derivatives.
PL354600A1 (en) Naphthyridine derivatives
CY2380B1 (en) Pde IV inhibiting 2-cyanoiminoimidazole derivatives.
EG24605A (en) Antihistaminic spiro compounds
ZA978809B (en) PDE IV inhibiting 2-cyanoiminoimidazole derivatives
HU9901911D0 (en) Diaza-spiro[3,5]nanone derivatives
ZA993853B (en) Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole].
ID23283A (id) SPIRO [PIPERIDINA-4,1'-PIROLO (3,4-c) PIROLO]
HK1040510A1 (zh) 氰聯苯衍化物
AU4720393A (en) Pyrazolopyridine derivatives as angiotensin ii antagonists
ZA966323B (en) Camptothecin derivatives.
ZA200200734B (en) Spiro compounds.
SI1198464T1 (en) 8-PHENYL-6,9-DIHYDRO-(1,2,4)TRIAZOLO(3,4-i)PURIN-5-ONE DERIVATIVES

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed